Section Arrow
Quote
OKUR.NASDAQ
- OnKure Therapeutics Inc
Quotes are at least 15-min delayed:2025/09/05 01:15 EDT
Regular Hours
Last
 2.69
-0.14 (-4.95%)
Day High 
2.86 
Prev. Close
2.83 
1-M High
2.975 
Volume 
105.94K 
Bid
2.35
Ask
2.65
Day Low
2.55 
Open
2.8 
1-M Low
1.91 
Market Cap 
38.29M 
Currency USD 
P/E 61.59 
%Yield -- 
10-SMA 2.78 
20-SMA 2.55 
50-SMA 2.45 
52-W High 19.9992 
52-W Low 1.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.46/-3.96
Enterprise Value
38.84M
Balance Sheet
Book Value Per Share
5.78
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PPBTPurple Biotech Ltd0.78-0.64-45.07%0PE
ADAPAdaptimmune Therapeutics plc0.051-0.0016-3.04%-- 
NBYNovaBay Pharmaceuticals4.22+1.54+57.46%1.14PE
ETHZETHZilla Corporation2.42-0.1-3.97%-- 
RXRXRecursion Pharmaceuticals4.52-0.11-2.38%-- 
Quotes are at least 15-min delayed：2025/09/05 01:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Thecompany operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.